Patents by Inventor James Gleason

James Gleason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10954194
    Abstract: The invention relates to a method of treating a subject who has cancer or a non-malignant tumor, the method comprising administering a therapeutically effective amount of a 18-20 member bi-polycyclic compound to the subject.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: March 23, 2021
    Assignees: Haro Pharmaceuticals Inc., The Royal Institution for the Advancement of Learning/ McGill University, Universite De Montreal
    Inventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
  • Publication number: 20200391880
    Abstract: A fretting buffer includes a matrix, a plurality of reinforcing fibers, and a lubricant disbursed substantially homogeneously in the matrix.
    Type: Application
    Filed: June 12, 2020
    Publication date: December 17, 2020
    Applicant: Roller Bearing Company of America, Inc.
    Inventors: Andrew Loutzenheiser, James Webb, Joe Solomon, Scott McNeil, Ryan Gleason, Jeffrey Post, Owen Bertelsen
  • Patent number: 10857006
    Abstract: Systems and devices for use as lower leg prosthetic devices that include a foot portion having anterior and posterior ends and a first surface having a protrusion that protrudes therefrom adjacent the posterior end of the foot portion, has a semispherical or hemispherical surface with a passage therethrough extending laterally relative to the foot portion. The systems and devices further include a toe portion pivotally coupled to the anterior end of the foot portion, and a plate portion configured to couple to an attachment device and thereby be functionally secured to a user. The plate portion has a recess configured to couple with the protrusion of the foot portion. A cylindrical rod is located within the lateral passage of the protrusion and has ends protruding therefrom on oppositely-disposed of the protrusion. The plate portion is pivotally coupled to the ends of the rod on oppositely-disposed lateral sides of the protrusion.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: December 8, 2020
    Assignee: Purdue Research Foundation
    Inventors: Haley Elizabeth Smith, Jennifer Anne Boehm, Rachel Nicole Berry, Sami Imad Labban, Allison Jean Gleason, Eric Allen Nauman, Quinton James Lasko
  • Patent number: 10820919
    Abstract: The present invention provides enhanced ESWL efficacy for therapeutic and operational outcomes. Device behavior and performance data is measured in-situ and analyzed for both intra-procedure and inter-procedure breadth of regard such that both therapy optimization and maintenance optimization engines are provided an accurate and current assessment of ESWL system and device state and performance. This feedback and control provides the ability to compensate in real time for the current patient therapy and offline for future patient therapy for machine/therapy idiosyncrasies and realize continuous calibration of system/devices to the performance required for maximum ESWL patient efficacy.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: November 3, 2020
    Assignee: TRANSLATIONAL TECHNOLOGIES, LLC
    Inventors: Andrew James Griffis, Christopher Mark Gleason
  • Patent number: 10807913
    Abstract: A polycrystalline diamond element includes a polycrystalline diamond table having a body of bonded diamond particles with interstitial regions. A first volume of the body includes an interstitial material and a second volume of the body has a lower concentration of interstitial material within the interstitial regions than the first volume. The polycrystalline diamond element includes an element face and a peripheral surface. The first volume is adjacent to a central portion of the element face and the second volume is adjacent to the peripheral surface. A method of processing a polycrystalline diamond element includes forming a concave region in the polycrystalline diamond element, exposing at least a portion of the concave region to a leaching solution, and removing at least a portion of the polycrystalline diamond material that was exposed to the leaching solution from the polycrystalline diamond element.
    Type: Grant
    Filed: February 11, 2014
    Date of Patent: October 20, 2020
    Assignee: US Synthetic Corporation
    Inventors: Joshua Adam Hawks, Ryan LeRoy Woodland, Jason Keith Wiggins, David Paul Miess, Mark Pehrson Chapman, Trevor Allen Olsen, Trent Neil Butcher, Michael James Gleason, Matthew Sinclair Brown, Julie Ann Kidd
  • Patent number: 10752591
    Abstract: The invention relates to a method of inhibiting loss of muscle mass or muscle function in a subject in need thereof, or a method of treating miofibers ex vivo, the method comprising administering a therapeutically effective amount of a 18-20 member bi-polycyclic compound to the subject or to the miofibers.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: August 25, 2020
    Assignees: Haro Pharmaceuticals Inc., The Royal Institution for the Advancement of Learning/McGill University, Universite De Montreal
    Inventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
  • Publication number: 20190389806
    Abstract: The invention relates to a method of inhibiting loss of muscle mass or muscle function in a subject in need thereof, or a method of treating miofibers ex vivo, the method comprising administering a therapeutically effective amount of a 18-20 member bi-polycyclic compound to the subject or to the miofibers.
    Type: Application
    Filed: July 3, 2019
    Publication date: December 26, 2019
    Inventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
  • Publication number: 20190389805
    Abstract: The invention relates to a method of treating a subject who has cancer or a non-malignant tumor, the method comprising administering a therapeutically effective amount of a 18-20 member bi-polycyclic compound to the subject.
    Type: Application
    Filed: July 3, 2019
    Publication date: December 26, 2019
    Inventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
  • Publication number: 20190381694
    Abstract: Embodiments of the invention are directed to cutting tool assemblies, material-removing machines that include cutting tool assemblies, and methods of use and operation thereof. In some embodiments, the cutting tool assemblies described herein may be used in material-removing machines that may remove target material. For example, the cutting tool assemblies may include one or more superhard working surfaces and/or one or more shields.
    Type: Application
    Filed: July 30, 2019
    Publication date: December 19, 2019
    Inventors: David P. Miess, Michael James Gleason, Samuel Earl Wilding, Regan Leland Burton, Paul Douglas Jones
  • Patent number: 10414069
    Abstract: Embodiments of the invention are directed to cutting tool assemblies, material-removing machines that include cutting tool assemblies, and methods of use and operation thereof. In some embodiments, the cutting tool assemblies described herein may be used in material-removing machines that may remove target material. For example, the cutting tool assemblies may include one or more superhard working surfaces and/or one or more shields.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: September 17, 2019
    Assignee: US SYNTHETIC CORPORATION
    Inventors: David P. Miess, Michael James Gleason, Samuel Earl Wilding, Regan Leland Burton, Paul Douglas Jones
  • Patent number: 10407337
    Abstract: According to some embodiments method for making an optical fiber preform comprises the steps of: (i) placing a plurality of rods with an outer surface having a coefficient of friction 0.02?COF?0.3 into an inner cavity of an apparatus; (ii) placing particulate glass material in the inner cavity between the rods and an inner wall of the mold cavity; and (iii) applying pressure against the particulate glass material to press the particulate glass material against the plurality of rods.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: September 10, 2019
    Assignee: Corning Incorporated
    Inventors: Daniel Robert Boughton, James Gerard Fagan, Larry Gleason Hubbard, Jr., Ji Wang
  • Patent number: 10391613
    Abstract: Embodiments of the invention relate generally to overmolded protective leaching masks, and methods of manufacturing and using the same for leaching superabrasive elements such as polycrystalline diamond elements. In an embodiment, a protective leaching mask assembly includes a superabrasive element including a central axis and a superabrasive table, and a protective mask overmolded onto at least a portion of the superabrasive element. The protective mask includes a base portion and at least one sidewall extending from the base portion and defining an opening generally opposite the base portion. The at least one sidewall includes an inner surface configured to abut with a selected portion of the superabrasive element being chemically resistant to a leaching agent and an outer surface sloping at an oblique angle relative to the central axis.
    Type: Grant
    Filed: December 1, 2015
    Date of Patent: August 27, 2019
    Assignee: US SYNTHETIC CORPORATION
    Inventor: Michael James Gleason
  • Patent number: 10377715
    Abstract: The invention relates to 18-20 member bi-polycyclic compounds, methods of making these compounds, and methods of using them in treating hyperproliferative disorders (e.g., cancer) and non-malignant tumors; promoting muscle formation; inhibiting muscle degeneration or the loss of muscle mass or muscle function; and myofibers ex vivo.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: August 13, 2019
    Assignees: Haro Pharmaceuticals Inc., The Royal Institution for the Advancement of Learning/ McGill University, Universite De Montreal
    Inventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
  • Patent number: 10265673
    Abstract: A protective leaching cup includes a rear wall, an opening defined in a portion of the protective leaching cup opposite the rear wall, and a side wall extending between the opening and the rear wall, the side wall and the rear wall defining a cavity within the protective leaching cup. The side wall has a seal region adjacent the opening of the protective leaching cup, the seal region having a first inner diameter, and an encapsulating region extending between the seal region and the rear wall, the encapsulating region having a second inner diameter that is greater than the first inner diameter.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: April 23, 2019
    Assignee: US SYNTHETIC CORPORATION
    Inventors: Michael James Gleason, Jair Jahaziel Gonzalez
  • Patent number: 10183867
    Abstract: A method of processing a polycrystalline diamond element may include assembling a polycrystalline diamond element, a liner, and a protective leaching cup such that the liner is disposed between the polycrystalline diamond element and the protective leaching cup and a seal region of the protective leaching cup abuts a surface portion of the polycrystalline diamond element. The method may also include exposing a portion of the polycrystalline diamond element to a leaching agent. A method of processing a polycrystalline diamond element may also include surrounding a portion of a polycrystalline diamond element with a liner, inserting the liner and the polycrystalline diamond element into a protective leaching cup such that the liner is disposed between the polycrystalline diamond element and the protective leaching cup, and exposing another portion of the polycrystalline diamond element to a leaching agent.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: January 22, 2019
    Assignee: US SYNTHETIC CORPORATION
    Inventor: Michael James Gleason
  • Publication number: 20180362467
    Abstract: The invention relates to 18-20 member bi-polycyclic compounds, methods of making these compounds, and methods of using them in treating hyperproliferative disorders (e.g., cancer) and non-malignant tumors; promoting muscle formation; inhibiting muscle degeneration or the loss of muscle mass or muscle function; and myofibers ex vivo.
    Type: Application
    Filed: December 6, 2017
    Publication date: December 20, 2018
    Inventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
  • Patent number: D866634
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: November 12, 2019
    Assignee: CISCO TECHNOLOGY, INC.
    Inventors: Peter W. Gleason, Nicholas James Kaoru Kawamoto, Nicholas Dye Abalos, Ian Matthew Snyder, Jennifer Ouk
  • Patent number: D874533
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: February 4, 2020
    Assignee: CISCO TECHNOLOGY, INC.
    Inventors: Kyunyoung Park, Nicholas James Kaoru Kawamoto, Peter W. Gleason, Nicholas Dye Abalos, Ian Matthew Snyder, Jennifer Ouk
  • Patent number: D875808
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: February 18, 2020
    Assignee: CISCO TECHNOLOGY, INC.
    Inventors: Kyunyoung Park, Nicholas James Kaoru Kawamoto, Peter W. Gleason, Nicholas Dye Abalos, Ian Matthew Snyder, Jennifer Ouk
  • Patent number: D904483
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: December 8, 2020
    Assignee: CISCO TECHNOLOGY, INC.
    Inventors: Peter W. Gleason, Nicholas James Kaoru Kawamoto, Nicholas Dye Abalos, Ian Matthew Snyder, Jennifer Ouk